METHIMAZOLE-INDUCED AGRANULOCYTOSIS IN JAPANESE PATIENTS WITH GRAVES’ DISEASE

1989 ◽  
Vol 30 (5) ◽  
pp. 525-530 ◽  
Author(s):  
HAJIME TAMAI ◽  
YUKIHIKO TAKAICHI ◽  
TETSUYA MORITA ◽  
GEN KOMAKI ◽  
SUNAO MATSUBAYASHI ◽  
...  
1977 ◽  
Vol 86 (4) ◽  
pp. 754-757 ◽  
Author(s):  
A. Kawa ◽  
S. Nakamura ◽  
M. Nakazawa ◽  
S. Sakaguchi ◽  
T. Kawabata ◽  
...  

ABSTRACT Thirty-three Japanese patients with Graves' disease and 106 healthy controls living in the Kagoshima area, the southernmost part of the Japanese mainland, were HLA typed by the NIH method. None of them were related to each other. The only antigen showing an increased frequency in Japanese patients with Graves' disease was HLA-BW35 (corrected P < 0.02). A decreased frequency of B5 in the patients was also statistically significant (corrected P < 0.02).


Thyroid ◽  
2000 ◽  
Vol 10 (6) ◽  
pp. 475-480 ◽  
Author(s):  
Yoshiyuki Ban ◽  
Yoshio Ban ◽  
Matsuo Taniyama ◽  
Takashi Katagiri

Cornea ◽  
2000 ◽  
Vol 19 (Supplement 2) ◽  
pp. S130
Author(s):  
Yoshitsugu Tagawa ◽  
Rieko Kishimoto ◽  
Yasufumi Amino ◽  
Kazuyuki Yamamoto ◽  
Takafumi Nakano ◽  
...  

1994 ◽  
Vol 41 (6) ◽  
pp. 599-603 ◽  
Author(s):  
EIYU KATSUREN ◽  
TAKUYA AWATA ◽  
CHIAKI MATSUMOTO ◽  
KUNIHIRO YAMAMOTO

2019 ◽  
Vol 104 (12) ◽  
pp. 6338-6344
Author(s):  
Shinsuke Noso ◽  
Naru Babaya ◽  
Yoshihisa Hiromine ◽  
Hiroyuki Ito ◽  
Yasunori Taketomo ◽  
...  

Abstract Context and Objectives Thyrotoxic periodic paralysis (TPP) is an acute complication of thyrotoxicosis that can be lethal. TPP is rare in Caucasians but often affects young men in East Asian populations. This study aimed to clarify the contribution of KCNJ18 to susceptibility to TPP in East Asian populations. Participants and Methods The study comprised 635 participants including 13 Japanese patients with TPP, 208 Japanese patients with Graves disease without TPP, and 414 healthy control subjects from the Japanese (n = 208), Korean (n = 111), and Caucasian populations (n = 95). DNA samples from 29 participants (13 with TPP, 8 with Graves disease, and 8 controls) were sequenced for KCNJ18, and all participants (n = 635) were genotyped for six variants of KCNJ18 and a polymorphism of KCNJ2 (rs312691). Results Six single-nucleotide variants (SNVs) with amino acid substitutions were identified by direct sequencing of KCNJ18. Among these, four SNVs comprised three haplotypes under strong linkage disequilibrium. Haplotype 1 (AAAG) of KCNJ18 was significantly associated with susceptibility to TPP in the Japanese population (OR = 19.6; 95% CI, 1.5 to 256.9; P = 0.013). Haplotype frequencies in the general East Asian (Japanese and Korean) and Caucasian populations differed significantly (haplotype 1: 80.8% vs 48.4%, P = 1.1×10−27). Conclusion A major haplotype of KCNJ18 in East Asian populations is significantly associated with susceptibility to TPP. The haplotype is much more common in East Asian than Caucasian populations, suggesting its contribution to the high prevalence of TPP in East Asian populations.


2008 ◽  
Vol 158 (6) ◽  
pp. 817-822 ◽  
Author(s):  
Mina Hayashi ◽  
Tsuyoshi Kouki ◽  
Nobuyuki Takasu ◽  
Sumito Sunagawa ◽  
Ichiro Komiya

ObjectiveProgrammed cell death-1 (PD-1) and its ligands (PD-L1 and PD-L2) inhibit T-cell proliferation and activation. This inhibition down-regulates the immune responses. The association of a PD-L1 polymorphism with Graves' disease (GD) was studied.DesignThe association of an A/C polymorphism at position 8923 in PD-L1 intron 4 with GD was studied.PatientsThe study included 327 GD patients and 192 controls, of which 252 GD patients were followed over 5–10 years.MeasurementsPD-L1 intron 4 position 8923 A/C polymorphism was typed using the PCR-restriction fragment length polymorphism method.ResultsThe A/C genotype frequencies were significantly different between GD patients and controls. The A/C and C/C frequencies were higher in GD patients than in controls. The A/A frequencies were lower in GD patients than in controls. C-allele frequency was higher in GD patients than in controls. A total of 252 GD patients were followed over 5–10 years; 200 had discontinued antithyroid drugs (ATD) while 52 continued to take ATD. Of these 200, 176 continued to be in remission and 24 had relapsed into hyperthyroidism. Significant differences in the duration of positive TBII, positive thyroid-stimulating antibodies, and ATD treatment were noted between the patients in remission and those that had relapsed. Significant differences in the A- and C-allele frequencies were noted between the two. The C-allele frequency was higher in GD patients who did not achieve remission than in those who achieved remission.ConclusionAn A/C polymorphism at position 8923 in PD-L1 is associated with GD. The PD-L1 polymorphism plays a role in GD development. GD patients with the C allele at position 8923 in PD-L1 gene had difficulty in achieving remission.


1992 ◽  
Vol 36 (1) ◽  
pp. 75-82 ◽  
Author(s):  
Daisuke Inoue ◽  
Kaoru Sato ◽  
Tetsuya Enomolo ◽  
Hideo Sugawa ◽  
Masahiro Maeda ◽  
...  

Thyroid ◽  
2000 ◽  
Vol 10 (5) ◽  
pp. 375-380 ◽  
Author(s):  
Yoshiyuki Ban ◽  
Yoshio Ban ◽  
Matsuo Taniyama ◽  
Takashi Katagiri

Sign in / Sign up

Export Citation Format

Share Document